These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors. Carbotti G; Orengo AM; Mezzanzanica D; Bagnoli M; Brizzolara A; Emionite L; Puppo A; Centurioni MG; Bruzzone M; Marroni P; Rossello A; Canevari S; Ferrini S; Fabbi M Int J Cancer; 2013 Jun; 132(11):2597-605. PubMed ID: 23169448 [TBL] [Abstract][Full Text] [Related]
7. Acrylamide and Glycidamide Hemoglobin Adducts and Epithelial Ovarian Cancer: A Nested Case-Control Study in Nonsmoking Postmenopausal Women from the EPIC Cohort. Obón-Santacana M; Lujan-Barroso L; Travis RC; Freisling H; Ferrari P; Severi G; Baglietto L; Boutron-Ruault MC; Fortner RT; Ose J; Boeing H; Menéndez V; Sánchez-Cantalejo E; Chamosa S; Castaño JM; Ardanaz E; Khaw KT; Wareham N; Merritt MA; Gunter MJ; Trichopoulou A; Papatesta EM; Klinaki E; Saieva C; Tagliabue G; Tumino R; Sacerdote C; Mattiello A; Bueno-de-Mesquita HB; Peeters PH; Onland-Moret NC; Idahl A; Lundin E; Weiderpass E; Vesper HW; Riboli E; Duell EJ Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):127-34. PubMed ID: 26598536 [TBL] [Abstract][Full Text] [Related]
8. Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European Prospective Investigation into Cancer and Nutrition. Ose J; Fortner RT; Rinaldi S; Schock H; Overvad K; Tjonneland A; Hansen L; Dossus L; Fournier A; Baglietto L; Romieu I; Kuhn E; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Masala G; Sieri S; Tumino R; Sacerdote C; Mattiello A; Ramon Quiros J; Obón-Santacana M; Larrañaga N; Chirlaque MD; Sánchez MJ; Barricarte A; Peeters PH; Bueno-de-Mesquita HB; Onland-Moret NC; Brändstedt J; Lundin E; Idahl A; Weiderpass E; Gram IT; Lund E; Kaw KT; Travis RC; Merritt MA; Gunther MJ; Riboli E; Kaaks R Int J Cancer; 2015 Jan; 136(2):399-410. PubMed ID: 24890047 [TBL] [Abstract][Full Text] [Related]
9. Circulating sex steroids during pregnancy and maternal risk of non-epithelial ovarian cancer. Chen T; Surcel HM; Lundin E; Kaasila M; Lakso HA; Schock H; Kaaks R; Koskela P; Grankvist K; Hallmans G; Pukkala E; Zeleniuch-Jacquotte A; Toniolo P; Lehtinen M; Lukanova A Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):324-36. PubMed ID: 21177423 [TBL] [Abstract][Full Text] [Related]
10. Detection of phosphatidylserine-positive exosomes as a diagnostic marker for ovarian malignancies: a proof of concept study. Lea J; Sharma R; Yang F; Zhu H; Ward ES; Schroit AJ Oncotarget; 2017 Feb; 8(9):14395-14407. PubMed ID: 28122335 [TBL] [Abstract][Full Text] [Related]
11. Early pregnancy IGF-I and placental GH and risk of epithelial ovarian cancer: A nested case-control study. Schock H; Fortner RT; Surcel HM; Grankvist K; Pukkala E; Lehtinen M; Lundin E Int J Cancer; 2015 Jul; 137(2):439-47. PubMed ID: 25516257 [TBL] [Abstract][Full Text] [Related]
12. Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer. Simmons AR; Fourkala EO; Gentry-Maharaj A; Ryan A; Sutton MN; Baggerly K; Zheng H; Lu KH; Jacobs I; Skates S; Menon U; Bast RC Cancer Prev Res (Phila); 2019 Jun; 12(6):391-400. PubMed ID: 30967390 [TBL] [Abstract][Full Text] [Related]
13. Agreement for tumor grade of ovarian carcinoma: analysis of archival tissues from the surveillance, epidemiology, and end results residual tissue repository. Matsuno RK; Sherman ME; Visvanathan K; Goodman MT; Hernandez BY; Lynch CF; Ioffe OB; Horio D; Platz C; Altekruse SF; Pfeiffer RM; Anderson WF Cancer Causes Control; 2013 Apr; 24(4):749-57. PubMed ID: 23378140 [TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women. Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Weiderpass E; Persson IR J Natl Cancer Inst; 2002 Apr; 94(7):497-504. PubMed ID: 11929950 [TBL] [Abstract][Full Text] [Related]
15. The risk of malignancy index (RMI) in diagnosis of ovarian malignancy. Moolthiya W; Yuenyao P Asian Pac J Cancer Prev; 2009; 10(5):865-8. PubMed ID: 20162854 [TBL] [Abstract][Full Text] [Related]
16. Epithelial Ovarian Cancer with Endometriosis is not Associated with Menopausal Status: a Co-Association Study at Prapokklao Hospital. Muangtan S; Suknikhom W; Sananpanichkul P; Bhamarapravatana K; Suwannarurk K Asian Pac J Cancer Prev; 2018 May; 19(5):1337-1341. PubMed ID: 29802696 [TBL] [Abstract][Full Text] [Related]
17. Impact of Preoperative Serum Levels of CA 125 on Epithelial Ovarian Cancer Survival. Pradjatmo H; Pradjatmo H Asian Pac J Cancer Prev; 2016; 17(4):1881-6. PubMed ID: 27221870 [TBL] [Abstract][Full Text] [Related]
18. Identification of Tumor Antigens in Ovarian Cancers Using Local and Circulating Tumor-Specific Antibodies. Da Gama Duarte J; Quigley LT; Young AR; Hayashi M; Miyazawa M; Lopata A; Mancuso N; Mikami M; Behren A; Meeusen E Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681879 [TBL] [Abstract][Full Text] [Related]
19. LyGDI is a promising biomarker for ovarian cancer. Zhen H; Yang S; Wu H; Wang S; Lv J; Ma L; Zhang X Int J Gynecol Cancer; 2010 Apr; 20(3):316-22. PubMed ID: 20375790 [TBL] [Abstract][Full Text] [Related]
20. Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer. Asher V; Lee J; Innamaa A; Bali A Clin Transl Oncol; 2011 Jul; 13(7):499-503. PubMed ID: 21775277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]